{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:58Z","timestamp":1792097338453,"version":"4.4.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03399-z","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:06:03Z","timestamp":1788843963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing copper-iron crosstalk: A novel strategy to combat hepatocellular carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Xiuli","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-4375","authenticated-orcid":false,"given":"Zhongyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3399_CR1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/15548627.2022.2103961","volume":"19","author":"S Chouhan","year":"2023","unstructured":"Chouhan S, Sawant M, Weimholt C, et al. TNK2\/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. Autophagy. 2023;19:1000\u201325.","journal-title":"Autophagy"},{"key":"3399_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40170-018-0187-2","volume":"6","author":"D Athavale","year":"2018","unstructured":"Athavale D, Chouhan S, Pandey V, et al. Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9). Cancer Metab. 2018;6:16.","journal-title":"Cancer Metab"},{"key":"3399_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12038-017-9667-8","volume":"42","author":"R Kumari","year":"2017","unstructured":"Kumari R, Chouhan S, Singh S, et al. Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway. J Biosci. 2017;42:31\u201341.","journal-title":"J Biosci"},{"key":"3399_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep27558","volume":"6","author":"S Chouhan","year":"2016","unstructured":"Chouhan S, Singh S, Athavale D, et al. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Sci Rep. 2016;6:27558.","journal-title":"Sci Rep"},{"key":"3399_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"3399_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"YQ Wang","year":"2022","unstructured":"Wang YQ, Zhang L, Zhou FF. Cuproptosis: a new form of programmed cell death. Cell Mol Immunol. 2022;19:867\u20138.","journal-title":"Cell Mol Immunol"},{"key":"3399_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08204-9","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Dong R, Yuan B, et al. Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. Cell Death Dis. 2025;16:878.","journal-title":"Cell Death Dis"},{"key":"3399_CR8","volume":"14","author":"I Artusi","year":"2025","unstructured":"Artusi I, Rubin M, Cravin G, Cozza G. Ferroptosis in human diseases: fundamental roles and emerging therapeutic perspectives. Antioxidants (Basel). 2025;14:1411.","journal-title":"Antioxidants (Basel)"},{"key":"3399_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12935-025-03683-4","volume":"25","author":"R Zhang","year":"2025","unstructured":"Zhang R, Tan Y, Xu K, et al. Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment. Cancer Cell Int. 2025;25:137.","journal-title":"Cancer Cell Int"},{"key":"3399_CR10","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.96014","volume":"20","author":"X Zhu","year":"2024","unstructured":"Zhu X, Sha X, Zang Y, et al. Current Progress of Ferroptosis Study in Hepatocellular Carcinoma. Int J Biol Sci. 2024;20:3621\u201337.","journal-title":"Int J Biol Sci"},{"key":"3399_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-020-00065-y","author":"S Chouhan","year":"2020","unstructured":"Chouhan S, Singh S, Athavale D, et al. Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4. J Biosci. 2020. https:\/\/doi.org\/10.1007\/s12038-020-00065-y.","journal-title":"J Biosci"},{"key":"3399_CR12","doi-asserted-by":"crossref","first-page":"eadn4556","DOI":"10.1126\/scisignal.adn4556","volume":"17","author":"X Shi","year":"2024","unstructured":"Shi X, Zhou XZ, Chen G, et al. Targeting the postsynaptic scaffolding protein PSD-95 enhances BDNF signaling to mitigate depression-like behaviors in mice. Sci Signal. 2024;17:eadn4556.","journal-title":"Sci Signal"},{"key":"3399_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","volume":"14","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol. 2010;14:211\u20137.","journal-title":"Curr Opin Chem Biol"},{"key":"3399_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/a-2460-8999","volume":"45","author":"Z Mari\u00f1o","year":"2025","unstructured":"Mari\u00f1o Z, Schilsky ML. Wilson disease: novel diagnostic and therapeutic approaches. Semin Liver Dis. 2025;45:221\u201335.","journal-title":"Semin Liver Dis"},{"key":"3399_CR15","doi-asserted-by":"crossref","first-page":"s842","DOI":"10.1093\/ajcn\/63.5.842","volume":"63","author":"IH Scheinberg","year":"1996","unstructured":"Scheinberg IH, Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr. 1996;63:s842\u20135.","journal-title":"Am J Clin Nutr"},{"key":"3399_CR16","doi-asserted-by":"crossref","first-page":"841814","DOI":"10.3389\/fmolb.2022.841814","volume":"9","author":"V Oliveri","year":"2022","unstructured":"Oliveri V. Selective Targeting of Cancer Cells by Copper Ionophores: An Overview. Front Mol Biosci. 2022;9:841814.","journal-title":"Front Mol Biosci"},{"key":"3399_CR17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.molonc.2015.02.007","volume":"9","author":"JL Allensworth","year":"2015","unstructured":"Allensworth JL, Evans MK, Bertucci F, et al. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Mol Oncol. 2015;9:1155\u201368.","journal-title":"Mol Oncol"},{"key":"3399_CR18","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","volume":"7","author":"JR Kirshner","year":"2008","unstructured":"Kirshner JR, He S, Balasubramanyam V, et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther. 2008;7:2319\u201327.","journal-title":"Mol Cancer Ther"},{"key":"3399_CR19","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai M, Vo NH, Shin Ogawa L, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med. 2012;52:2142\u201350.","journal-title":"Free Radic Biol Med"},{"key":"3399_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:681\u20139.","journal-title":"Nat Chem Biol"},{"key":"3399_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41589-019-0315-5","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, et al. Author Correction: Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:757.","journal-title":"Nat Chem Biol"},{"key":"3399_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103302","author":"B Sun","year":"2024","unstructured":"Sun B, Ding P, Song YH, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2024.103302.","journal-title":"Redox Biol"},{"key":"3399_CR23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"3399_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301.","journal-title":"Biomed Pharmacother"},{"key":"3399_CR25","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang D, Tian Z, Zhang P, et al. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed Pharmacother. 2023;163:114830.","journal-title":"Biomed Pharmacother"},{"key":"3399_CR26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","volume":"42","author":"EA Rowland","year":"2018","unstructured":"Rowland EA, Snowden CK, Cristea IM. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr Opin Chem Biol. 2018;42:76\u201385.","journal-title":"Curr Opin Chem Biol"},{"key":"3399_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0300-483X(96)03554-8","volume":"117","author":"B Hultberg","year":"1997","unstructured":"Hultberg B, Andersson A, Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols in HeLa cell cultures. Toxicology. 1997;117:89\u201397.","journal-title":"Toxicology"},{"key":"3399_CR28","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson A, DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation. J Biol Chem. 2018;293:7522\u201330.","journal-title":"J Biol Chem"},{"key":"3399_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s11596-023-2755-0","volume":"43","author":"F Gao","year":"2023","unstructured":"Gao F, Yuan Y, Ding Y, et al. DLAT as a cuproptosis promoter and a molecular target of elesclomol in hepatocellular carcinoma. Curr Med Sci. 2023;43:526\u201338.","journal-title":"Curr Med Sci"},{"key":"3399_CR30","doi-asserted-by":"crossref","first-page":"e0179591","DOI":"10.1371\/journal.pone.0179591","volume":"12","author":"E Bernardinelli","year":"2017","unstructured":"Bernardinelli E, Costa R, Scantamburlo G, et al. Mis-targeting of the mitochondrial protein LIPT2 leads to apoptotic cell death. PLoS ONE. 2017;12:e0179591.","journal-title":"PLoS ONE"},{"key":"3399_CR31","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/bi049528x","volume":"43","author":"RM Cicchillo","year":"2004","unstructured":"Cicchillo RM, Iwig DF, Jones AD, et al. Lipoyl synthase requires two equivalents of S-adenosyl-L-methionine to synthesize one equivalent of lipoic acid. Biochemistry. 2004;43:6378\u201386.","journal-title":"Biochemistry"},{"key":"3399_CR32","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.celrep.2019.04.005","volume":"27","author":"M Ni","year":"2019","unstructured":"Ni M, Solmonson A, Pan C, et al. Functional Assessment of Lipoyltransferase-1 Deficiency in Cells, Mice, and Humans. Cell Rep. 2019;27:1376\u2013e13861376.","journal-title":"Cell Rep"},{"key":"3399_CR33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin CH, Chin Y, Zhou M, et al. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci. 2024;49:729\u201344.","journal-title":"Trends Biochem Sci"},{"key":"3399_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Y Qin","year":"2023","unstructured":"Qin Y, Liu Y, Xiang X, et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol Cancer. 2023;22:59.","journal-title":"Mol Cancer"},{"key":"3399_CR35","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, Xie L, Liu J, et al. Construction and validation of a cuproptosis-related prognostic model for glioblastoma. Front Immunol. 2023;14:1082974.","journal-title":"Front Immunol"},{"key":"3399_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/233136a0","volume":"233","author":"DO Hall","year":"1971","unstructured":"Hall DO, Cammack R, Rao KK. Role for ferredoxins in the origin of life and biological evolution. Nature. 1971;233:136\u20138.","journal-title":"Nature"},{"key":"3399_CR37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, Bick NR, Petrova B, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem. 2023;299:105046.","journal-title":"J Biol Chem"},{"key":"3399_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/HM9.0000000000000182","volume":"6","author":"Y Liu","year":"2026","unstructured":"Liu Y, Fang M, Li M, et al. Tamarixetin suppresses neuronal ferroptosis in ischemic stroke rats by targeting and facilitating nuclear factor erythroid-2\u2013related factor 2 expression. Acupunct Herb Med. 2026;6:73\u201390.","journal-title":"Acupunct Herb Med"},{"key":"3399_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/HM9.0000000000000183","volume":"6","author":"L Zhang","year":"2026","unstructured":"Zhang L, Wei Y, Xu X, et al. Ginseng and Rhubarb combination ameliorates ferroptosis in persistent inflammation, immunosuppression, and catabolism syndrome via the CaMKII\/HO-1 signaling pathway. Acupunct Herb Med. 2026;6:205\u201319.","journal-title":"Acupunct Herb Med"},{"key":"3399_CR40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","volume":"102","author":"T Ganz","year":"2003","unstructured":"Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783\u20138.","journal-title":"Blood"},{"key":"3399_CR41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chembiol.2020.03.016","volume":"27","author":"A Belavgeni","year":"2020","unstructured":"Belavgeni A, Meyer C, Stumpf J, et al. Ferroptosis and necroptosis in the kidney. Cell Chem Biol. 2020;27:448\u201362.","journal-title":"Cell Chem Biol"},{"key":"3399_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00204-023-03625-x","volume":"98","author":"Z Huang","year":"2024","unstructured":"Huang Z, Ma Y, Sun Z, et al. Ferroptosis: potential targets and emerging roles in pancreatic diseases. Arch Toxicol. 2024;98:75\u201394.","journal-title":"Arch Toxicol"},{"key":"3399_CR43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, et al. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"3399_CR44","doi-asserted-by":"crossref","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D. Iron Metabolism in Ferroptosis. Front Cell Dev Biol. 2020;8:590226.","journal-title":"Front Cell Dev Biol"},{"key":"3399_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369\u201379.","journal-title":"Cell Death Differ"},{"key":"3399_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9\u201317.","journal-title":"Nat Chem Biol"},{"key":"3399_CR47","first-page":"E4966","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci. 2016;113:E4966\u201375.","journal-title":"Proc Natl Acad Sci"},{"key":"3399_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"3399_CR49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0167-7799(97)01076-7","volume":"15","author":"I Gill","year":"1997","unstructured":"Gill I, Valivety R. Polyunsaturated fatty acids, Part 1: Occurrence, biological activities and applications. Trends Biotechnol. 1997;15:401\u20139.","journal-title":"Trends Biotechnol"},{"key":"3399_CR50","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111:5944\u201372.","journal-title":"Chem Rev"},{"key":"3399_CR51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/cr60143a003","volume":"46","author":"CE Frank","year":"1950","unstructured":"Frank CE. Hydrocarbon autoxidation. Chem Rev. 1950;46:155\u201369.","journal-title":"Chem Rev"},{"key":"3399_CR52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, et al. Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. Cell Chem Biol. 2019;26:420\u2013e432429.","journal-title":"Cell Chem Biol"},{"key":"3399_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12013-017-0799-0","volume":"75","author":"AW Girotti","year":"2017","unstructured":"Girotti AW, Korytowski W. Cholesterol Hydroperoxide Generation, Translocation, and Reductive Turnover in Biological Systems. Cell Biochem Biophys. 2017;75:413\u20139.","journal-title":"Cell Biochem Biophys"},{"key":"3399_CR54","first-page":"E4966","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113:E4966\u20134975.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3399_CR55","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acschembio.5b00900","volume":"11","author":"RP Abrams","year":"2016","unstructured":"Abrams RP, Carroll WL, Woerpel K. Five-membered ring peroxide selectively initiates ferroptosis in cancer cells. ACS Chem Biol. 2016;11:1305\u201312.","journal-title":"ACS Chem Biol"},{"key":"3399_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368:85\u20139.","journal-title":"Science"},{"key":"3399_CR57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2019.151058","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang H, Liu C, Zhao Y, Gao G. Mitochondria regulation in ferroptosis. Eur J Cell Biol. 2020;99:151058.","journal-title":"Eur J Cell Biol"},{"key":"3399_CR58","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29:2185\u2013208.","journal-title":"Mol Ther"},{"key":"3399_CR59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354-363. e353.","journal-title":"Mol Cell"},{"key":"3399_CR60","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem Biophys Res Commun. 2016;478:838\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"3399_CR61","volume":"10","author":"H-Y Lee","year":"2021","unstructured":"Lee H-Y, Nga HT, Tian J, Yi H-S. Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells. 2021;10:1901.","journal-title":"Cells"},{"key":"3399_CR62","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/onc.2015.32","volume":"34","author":"X Sun","year":"2015","unstructured":"Sun X, Ou Z, Xie M, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015;34:5617\u201325.","journal-title":"Oncogene"},{"key":"3399_CR63","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447:864\u20138.","journal-title":"Nature"},{"key":"3399_CR64","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"key":"3399_CR65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2011.02.001","volume":"508","author":"N Harada","year":"2011","unstructured":"Harada N, Kanayama M, Maruyama A, et al. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys. 2011;508:101\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"3399_CR66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/84152","volume":"8","author":"CK Wu","year":"2001","unstructured":"Wu CK, Dailey HA, Rose JP, et al. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat Struct Biol. 2001;8:156\u201360.","journal-title":"Nat Struct Biol"},{"key":"3399_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10534-018-0111-9","volume":"31","author":"ET Zakharova","year":"2018","unstructured":"Zakharova ET, Sokolov AV, Pavlichenko NN, et al. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals. 2018;31:425\u201343.","journal-title":"Biometals"},{"key":"3399_CR68","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u2013.","journal-title":"Science"},{"key":"3399_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4302","author":"EM Terzi","year":"2021","unstructured":"Terzi EM, Sviderskiy VO, Alvarez SW, et al. Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abg4302.","journal-title":"Sci Adv"},{"key":"3399_CR70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"3399_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0288-x","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang YL, Zhuang L, Gan BY. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun. 2018. https:\/\/doi.org\/10.1186\/s40880-018-0288-x.","journal-title":"Cancer Commun"},{"key":"3399_CR72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2024.06.006","volume":"222","author":"HJ Li","year":"2024","unstructured":"Li HJ, Li YC, Yu YH, et al. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF\/Cu-induced cuproptosis in myelodysplastic syndromes. Free Radic Biol Med. 2024;222:130\u201348.","journal-title":"Free Radic Biol Med"},{"key":"3399_CR73","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"3399_CR74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BS9.0000000000000117","volume":"4","author":"DR Nie","year":"2022","unstructured":"Nie DR, Chen CT, Li YQ, Zeng CW. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis. Blood Sci. 2022;4:152\u20134.","journal-title":"Blood Sci"},{"key":"3399_CR75","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1111\/iwj.14264","volume":"20","author":"M Chen","year":"2023","unstructured":"Chen M, Liang H, Chen M, et al. Risk factors for surgical site infection in patients with gastric cancer: a meta-analysis. Int Wound J. 2023;20:3884\u201397.","journal-title":"Int Wound J"},{"key":"3399_CR76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","volume":"7","author":"Hepatocellular carcinoma","year":"2021","unstructured":"Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:7.","journal-title":"Nat Rev Dis Primers"},{"key":"3399_CR77","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju GP, Dariya B, Kasa P, et al. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 2022;86:622\u201332.","journal-title":"Semin Cancer Biol"},{"key":"3399_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114791","volume":"163","author":"D Guan","year":"2023","unstructured":"Guan D, Zhao L, Shi X, et al. Copper in cancer: from pathogenesis to therapy. Biomed Pharmacother. 2023;163:114791.","journal-title":"Biomed Pharmacother"},{"key":"3399_CR79","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, Berisa M, Tavarez DA, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12:7311.","journal-title":"Nat Commun"},{"key":"3399_CR80","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1177\/0300060518798507","volume":"46","author":"X Zhang","year":"2018","unstructured":"Zhang X, Yang Q. Association between serum copper levels and lung cancer risk: a meta-analysis. J Int Med Res. 2018;46:4863\u201373.","journal-title":"J Int Med Res"},{"key":"3399_CR81","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102\u201313.","journal-title":"Nat Rev Cancer"},{"key":"3399_CR82","doi-asserted-by":"crossref","first-page":"e0237370","DOI":"10.1371\/journal.pone.0237370","volume":"15","author":"Y Tamai","year":"2020","unstructured":"Tamai Y, Iwasa M, Eguchi A, et al. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. PLoS ONE. 2020;15:e0237370.","journal-title":"PLoS ONE"},{"key":"3399_CR83","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.18632\/aging.205334","volume":"15","author":"X Li","year":"2023","unstructured":"Li X, Wang J, Guo Z, et al. Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. Aging. 2023;15:15084\u2013113.","journal-title":"Aging"},{"key":"3399_CR84","doi-asserted-by":"crossref","first-page":"1578693","DOI":"10.3389\/fmolb.2025.1578693","volume":"12","author":"Z Pang","year":"2025","unstructured":"Pang Z. Copper metabolism in hepatocellular carcinoma: from molecular mechanisms to therapeutic opportunities. Front Mol Biosci. 2025;12:1578693.","journal-title":"Front Mol Biosci"},{"key":"3399_CR85","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Sun B, Yao Y, et al. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma. Front Immunol. 2022;13:996308.","journal-title":"Front Immunol"},{"key":"3399_CR86","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1039\/d0mt00156b","volume":"12","author":"CI Davis","year":"2020","unstructured":"Davis CI, Gu X, Kiefer RM, et al. Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation. Metallomics. 2020;12:1995\u20132008.","journal-title":"Metallomics"},{"key":"3399_CR87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tcb.2022.07.006","volume":"33","author":"SK Das","year":"2023","unstructured":"Das SK, Lewis BA, Levens D. MYC: a complex problem. Trends Cell Biol. 2023;33:235\u201346.","journal-title":"Trends Cell Biol"},{"key":"3399_CR88","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.18632\/oncotarget.24282","volume":"9","author":"C Porcu","year":"2018","unstructured":"Porcu C, Antonucci L, Barbaro B, et al. Copper\/MYC\/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. Oncotarget. 2018;9:9325\u201343.","journal-title":"Oncotarget"},{"key":"3399_CR89","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.onc.1208207","volume":"24","author":"S Elchuri","year":"2005","unstructured":"Elchuri S, Oberley TD, Qi W, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24:367\u201380.","journal-title":"Oncogene"},{"key":"3399_CR90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41556-021-00822-7","volume":"24","author":"A Das","year":"2022","unstructured":"Das A, Ash D, Fouda AY, et al. Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nat Cell Biol. 2022;24:35\u201350.","journal-title":"Nat Cell Biol"},{"key":"3399_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07452-w","volume":"7","author":"EMH Yee","year":"2017","unstructured":"Yee EMH, Brandl MB, Pasquier E, et al. Dextran-catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells. Sci Rep. 2017;7:7638.","journal-title":"Sci Rep"},{"key":"3399_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020351","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang B, Fan F, et al. COMMD3 regulates copper metabolism via the ATOX1-ATP7A-LOX axis to promote multiple myeloma progression. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13020351.","journal-title":"Biomedicines"},{"key":"3399_CR93","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13046-023-02663-8","volume":"42","author":"JL Hancock","year":"2023","unstructured":"Hancock JL, Kalimutho M, Straube J, et al. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. J Exp Clin Cancer Res. 2023;42:90.","journal-title":"J Exp Clin Cancer Res"},{"key":"3399_CR94","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.7150\/jca.62454","volume":"13","author":"W Cheng","year":"2022","unstructured":"Cheng W, Cheng Z, Zhang C, et al. Investigating the Association between COMMD3 Expression and the Prognosis of Hepatocellular Carcinoma. J Cancer. 2022;13:1871\u201381.","journal-title":"J Cancer"},{"key":"3399_CR95","volume":"2022","author":"T Zhu","year":"2022","unstructured":"Zhu T, Peng X, Cheng Z, et al. COMMD3 expression affects angiogenesis through the HIF1\u03b1\/VEGF\/NF-\u03baB signaling pathway in hepatocellular carcinoma in vitro and in vivo. Oxid Med Cell Longev. 2022;2022:1655502.","journal-title":"Oxid Med Cell Longev"},{"key":"3399_CR96","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ijc.1537","volume":"94","author":"J Yoshii","year":"2001","unstructured":"Yoshii J, Yoshiji H, Kuriyama S, et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 2001;94:768\u201373.","journal-title":"Int J Cancer"},{"key":"3399_CR97","first-page":"1369","volume":"10","author":"H Yoshiji","year":"2003","unstructured":"Yoshiji H, Kuriyama S, Yoshii J, et al. The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression. Oncol Rep. 2003;10:1369\u201373.","journal-title":"Oncol Rep"},{"key":"3399_CR98","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.10740","volume":"102","author":"M Moriguchi","year":"2002","unstructured":"Moriguchi M, Nakajima T, Kimura H, et al. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. Int J Cancer. 2002;102:445\u201352.","journal-title":"Int J Cancer"},{"key":"3399_CR99","doi-asserted-by":"crossref","first-page":"51151","DOI":"10.18632\/oncotarget.17712","volume":"8","author":"P Ding","year":"2017","unstructured":"Ding P, Zhang X, Jin S, et al. CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells. Oncotarget. 2017;8:51151\u201363.","journal-title":"Oncotarget"},{"key":"3399_CR100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","volume":"61","author":"Q Huang","year":"2014","unstructured":"Huang Q, Li J, Xing J, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway. J Hepatol. 2014;61:859\u201366.","journal-title":"J Hepatol"},{"key":"3399_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101264","author":"T Xing","year":"2023","unstructured":"Xing T, Li L, Chen YR, et al. Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma. Cell Rep Med. 2023. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101264.","journal-title":"Cell Rep Med"},{"key":"3399_CR102","doi-asserted-by":"crossref","first-page":"112550","DOI":"10.1016\/j.jinorgbio.2024.112550","volume":"256","author":"M Jiang","year":"2024","unstructured":"Jiang M, Yan Q, Fu Y, et al. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer. J Inorg Biochem. 2024;256:112550.","journal-title":"J Inorg Biochem"},{"key":"3399_CR103","volume":"117","author":"X Shi","year":"2024","unstructured":"Shi X, Shi D, Yin Y, et al. Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma. Cell Signal. 2024;117:111072.","journal-title":"Cell Signal"},{"key":"3399_CR104","first-page":"e1904","volume":"6","author":"S Li","year":"2023","unstructured":"Li S, Weng J, Xiao C, et al. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features. Cancer Rep (Hoboken). 2023;6:e1904.","journal-title":"Cancer Rep (Hoboken)"},{"key":"3399_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00358-w","volume":"18","author":"Y Chen","year":"2023","unstructured":"Chen Y, Tang L, Huang W, et al. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma. Biol Direct. 2023;18:4.","journal-title":"Biol Direct"},{"key":"3399_CR106","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1168769","volume":"13","author":"Y Quan","year":"2023","unstructured":"Quan Y, Li W, Yan R, et al. Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1. Front Oncol. 2023;13:1168769.","journal-title":"Front Oncol"},{"key":"3399_CR107","first-page":"5590","volume":"13","author":"B Quan","year":"2023","unstructured":"Quan B, Liu W, Yao F, et al. LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13:5590\u2013609.","journal-title":"Am J Cancer Res"},{"key":"3399_CR108","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s42003-025-08101-z","volume":"8","author":"C Wu","year":"2025","unstructured":"Wu C, Long L, Wang M, et al. Copper-mediated SEC14L3 promotes cuproptosis to inhibit hepatocellular carcinoma growth via ERK\/YY1\/FDX1 axis. Commun Biol. 2025;8:658.","journal-title":"Commun Biol"},{"key":"3399_CR109","doi-asserted-by":"crossref","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, Ding P, Song Y, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75:103302.","journal-title":"Redox Biol"},{"key":"3399_CR110","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.21037\/jgo-24-609","volume":"15","author":"C Xia","year":"2024","unstructured":"Xia C, Chen Y, Zhu Y, et al. Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis. J Gastrointest Oncol. 2024;15:2230\u201351.","journal-title":"J Gastrointest Oncol"},{"key":"3399_CR111","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou H, Zhai X, et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14:733.","journal-title":"Cell Death Dis"},{"key":"3399_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/polym16172418","author":"X Li","year":"2024","unstructured":"Li X, Tang C, Ye H, Fang C. Injectable hydrogel-encapsulating Pickering emulsion for overcoming lenvatinib-resistant hepatocellular carcinoma via cuproptosis induction and stemness inhibition. Polymers (Basel). 2024. https:\/\/doi.org\/10.3390\/polym16172418.","journal-title":"Polymers (Basel)"},{"key":"3399_CR113","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12575-023-00222-1","volume":"25","author":"X Meng","year":"2023","unstructured":"Meng X, Peng X, Ouyang W, et al. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation. Biol Proced Online. 2023;25:32.","journal-title":"Biol Proced Online"},{"key":"3399_CR114","volume":"28","author":"K Guo","year":"2024","unstructured":"Guo K, Wang T, Yin J, et al. Identification of cuproptosis-related patterns predict prognosis and immunotherapy response in hepatocellular carcinoma. J Cell Mol Med. 2024;28:e70224.","journal-title":"J Cell Mol Med"},{"key":"3399_CR115","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12935-023-03207-y","volume":"24","author":"JQ Mo","year":"2024","unstructured":"Mo JQ, Zhang SY, Li Q, et al. Immunomodulation of cuproptosis and ferroptosis in liver cancer. Cancer Cell Int. 2024;24:22.","journal-title":"Cancer Cell Int"},{"key":"3399_CR116","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.2147\/JIR.S432111","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Han Z, Wang Y, et al. Targeting ferroptosis in bone-related diseases: facts and perspectives. J Inflamm Res. 2023;16:4661\u201377.","journal-title":"J Inflamm Res"},{"key":"3399_CR117","doi-asserted-by":"crossref","first-page":"102122","DOI":"10.1016\/j.redox.2021.102122","volume":"46","author":"X Ren","year":"2021","unstructured":"Ren X, Li Y, Zhou Y, et al. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis. Redox Biol. 2021;46:102122.","journal-title":"Redox Biol"},{"key":"3399_CR118","doi-asserted-by":"crossref","first-page":"103007","DOI":"10.1016\/j.redox.2023.103007","volume":"69","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zhou C, Ren X, et al. Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biol. 2024;69:103007.","journal-title":"Redox Biol"},{"key":"3399_CR119","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res. 2023;42:142.","journal-title":"J Exp Clin Cancer Res"},{"key":"3399_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020544","author":"Z Mao","year":"2023","unstructured":"Mao Z, Nie Y, Jia W, et al. Revealing prognostic and immunotherapy-sensitive characteristics of a novel cuproptosis-related LncRNA model in hepatocellular carcinoma patients by genomic analysis. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15020544.","journal-title":"Cancers (Basel)"},{"key":"3399_CR121","first-page":"2442","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, Guo L, Zhang B, et al. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. Am J Cancer Res. 2019;9:2442\u201355.","journal-title":"Am J Cancer Res"},{"key":"3399_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01027-5","volume":"14","author":"M Yi","year":"2021","unstructured":"Yi M, Niu M, Xu L, et al. Regulation of PD-L1 expression in the tumor microenvironment. J Hematol Oncol. 2021;14:10.","journal-title":"J Hematol Oncol"},{"key":"3399_CR123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1055-9965.EPI-13-0733","volume":"23","author":"A Fonseca-Nunes","year":"2014","unstructured":"Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk\u2014a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23:12\u201331.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3399_CR124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1\u2010NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173\u201384.","journal-title":"Hepatology"},{"key":"3399_CR125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.canlet.2014.11.014","volume":"356","author":"C Louandre","year":"2015","unstructured":"Louandre C, Marcq I, Bouhlal H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Lett. 2015;356:971\u20137.","journal-title":"Cancer Lett"},{"key":"3399_CR126","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138.","journal-title":"Nat Chem Biol"},{"key":"3399_CR127","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.12659\/MSM.906639","volume":"23","author":"X-J Sun","year":"2017","unstructured":"Sun X-J, Xu G-L. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in patients with hepatocellular carcinoma and its prognosis. Med Sci monitor: Int Med J experimental Clin Res. 2017;23:4343.","journal-title":"Med Sci monitor: Int Med J experimental Clin Res"},{"key":"3399_CR128","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao F, Deng Y, Zhao Y, et al. A targetable LIFR\u2009\u2013\u2009NF-\u03baB\u2013 LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12:7333.","journal-title":"Nat Commun"},{"key":"3399_CR129","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.7150\/ijbs.45050","volume":"16","author":"J-y Liang","year":"2020","unstructured":"Liang J-y, Wang D-s, Lin H-c, et al. A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int J Biol Sci. 2020;16:2430.","journal-title":"Int J Biol Sci"},{"key":"3399_CR130","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"Iseda N, Itoh S, Toshida K, et al. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci. 2022;113:2272\u201387.","journal-title":"Cancer Sci"},{"key":"3399_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05137-5","volume":"13","author":"J Grube","year":"2022","unstructured":"Grube J, Woitok MM, Mohs A, et al. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression. Cell Death Dis. 2022;13:704.","journal-title":"Cell Death Dis"},{"key":"3399_CR132","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/biology15010067","volume":"15","author":"D Quaranto","year":"2026","unstructured":"Quaranto D, DeSouza NR, Carnazza M, et al. Ferroptosis\u2014The Double-Edged Sword in Cancer: Mechanisms of Tumor Suppression\/Resistance and Therapeutic Manipulation. Biology. 2026;15:67.","journal-title":"Biology"},{"key":"3399_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02484-y","volume":"11","author":"N Liu","year":"2025","unstructured":"Liu N, Wu T, Han G, Chen M. Exosome-mediated ferroptosis in the tumor microenvironment: from molecular mechanisms to clinical application. Cell Death Discov. 2025;11:221.","journal-title":"Cell Death Discov"},{"key":"3399_CR134","volume":"376","author":"Z Li","year":"2025","unstructured":"Li Z, Gong Y, Okeke ES, et al. Novel insights into DBP-induced zebrafish liver inflammatory damage: ferroptosis activating the HMGB1-TLR4-NF-\u03baB signaling pathway. Environ Pollut. 2025;376:126395.","journal-title":"Environ Pollut"},{"key":"3399_CR135","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.celrep.2016.09.076","volume":"17","author":"N Das","year":"2016","unstructured":"Das N, Dewan V, Grace PM, et al. HMGB1 activates proinflammatory signaling via TLR5 leading to allodynia. Cell Rep. 2016;17:1128\u201340.","journal-title":"Cell Rep"},{"key":"3399_CR136","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12672-024-01573-1","volume":"15","author":"C Gao","year":"2024","unstructured":"Gao C, Zhang H, Wang X. Current advances on the role of ferroptosis in tumor immune evasion. Discov Oncol. 2024;15:736.","journal-title":"Discov Oncol"},{"key":"3399_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99853-5","volume":"15","author":"J Ma","year":"2025","unstructured":"Ma J, Tang D, Cui G, et al. The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma. Sci Rep. 2025;15:14939.","journal-title":"Sci Rep"},{"key":"3399_CR138","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C-H, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Therapy. 2025;10:227.","journal-title":"Signal Transduct Target Therapy"},{"key":"3399_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-29557-3","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Li H, Liu S, et al. Ferroptosis mediated by ferritinophagy is involved in liver injury caused by sepsis. Sci Rep. 2025;15:45489.","journal-title":"Sci Rep"},{"key":"3399_CR140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Therapy. 2024;9:55.","journal-title":"Signal Transduct Target Therapy"},{"key":"3399_CR141","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2020-001369.","journal-title":"J Immunother Cancer"},{"key":"3399_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01229-y","author":"LY Chen","year":"2022","unstructured":"Chen LY, Min JX, Wang FD. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"key":"3399_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101304","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xiang Y, Wang QY, et al. Regulation of iron metabolism in ferroptosis: from mechanism research to clinical translation. J Pharm Anal. 2025. https:\/\/doi.org\/10.1016\/j.jpha.2025.101304.","journal-title":"J Pharm Anal"},{"key":"3399_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00347-7","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gu YX, Zhan M, et al. Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventions. Mol Biomed. 2025. https:\/\/doi.org\/10.1186\/s43556-025-00347-7.","journal-title":"Mol Biomed"},{"key":"3399_CR145","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/cam4.548","volume":"4","author":"M Nakano","year":"2015","unstructured":"Nakano M, Tanaka M, Kuromatsu R, et al. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. Cancer Med. 2015;4:1836\u201343.","journal-title":"Cancer Med"},{"key":"3399_CR146","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cancergen.2025.04.006","volume":"294\u2013295","author":"D Gu","year":"2025","unstructured":"Gu D, Sun Y, Wang J, et al. Metformin regulates ferroptosis in Skin cutaneous melanoma via ATF3\/NRF2 axis. Cancer Genet. 2025;294\u2013295:136\u201344.","journal-title":"Cancer Genet"},{"key":"3399_CR147","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"issue":"13","key":"3399_CR148","doi-asserted-by":"publisher","first-page":"e23788","DOI":"10.1096\/fj.202400840R","volume":"38","author":"R Wang","year":"2024","unstructured":"Wang R, Lv Y, Ni Z, et al. Intermittent hypoxia exacerbates metabolic dysfunction-associated fatty liver disease by aggravating hepatic copper deficiency-induced ferroptosis. FASEB J. 2024;38:e23788.","journal-title":"FASEB J"},{"key":"3399_CR149","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","volume":"64","author":"X Sun","year":"2016","unstructured":"Sun X, Niu X, Chen R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology. 2016;64:488\u2013500.","journal-title":"Hepatology"},{"key":"3399_CR150","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2017.07.136","volume":"491","author":"T Bai","year":"2017","unstructured":"Bai T, Wang S, Zhao Y, et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2017;491:919\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"3399_CR151","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","volume":"61","author":"L Devisscher","year":"2018","unstructured":"Devisscher L, Van Coillie S, Hofmans S, et al. Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J Med Chem. 2018;61:10126\u201340.","journal-title":"J Med Chem"},{"key":"3399_CR152","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang S, Zhu L, Li T, et al. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Rep Med. 2024;5:101415.","journal-title":"Cell Rep Med"},{"key":"3399_CR153","doi-asserted-by":"crossref","first-page":"e2203973","DOI":"10.1002\/advs.202203973","volume":"10","author":"B Tang","year":"2023","unstructured":"Tang B, Zhu J, Wang Y, et al. Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1\/L1 Response. Adv Sci (Weinh). 2023;10:e2203973.","journal-title":"Adv Sci (Weinh)"},{"key":"3399_CR154","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35:e2212267.","journal-title":"Adv Mater"},{"key":"3399_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121449","author":"WL Pan","year":"2022","unstructured":"Pan WL, Tan Y, Meng W, et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121449.","journal-title":"Biomaterials"},{"key":"3399_CR156","volume":"15","author":"J Liang","year":"2025","unstructured":"Liang J, Wang R, Wu H, et al. Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma. Front Oncol. 2025;15:1555858.","journal-title":"Front Oncol"},{"key":"3399_CR157","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42003-025-09497-4","volume":"9","author":"Q Jiang","year":"2026","unstructured":"Jiang Q, Peng C, Mao W, et al. METTL3-mediated m6A modification of FDX1 confers resistance to cuproptosis and promotes hepatocellular carcinoma progression. Commun Biol. 2026;9:222.","journal-title":"Commun Biol"},{"key":"3399_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.619242","author":"ZQ Liu","year":"2021","unstructured":"Liu ZQ, Wang LB, Liu L, et al. The identification and validation of two heterogenous subtypes and a risk signature based on ferroptosis in hepatocellular carcinoma. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.619242.","journal-title":"Front Oncol"},{"key":"3399_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041623","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Ma HH, Lai ZL. The role of ferroptosis and cuproptosis in curcumin against hepatocellular carcinoma. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28041623.","journal-title":"Molecules"},{"key":"3399_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15060722","author":"Q Zhu","year":"2026","unstructured":"Zhu Q, Zhang YY, Zhu XY, et al. Targeting cuproptosis and ferroptosis via a ROS-responsive nanoplatform for enhanced synergistic therapy against hepatocellular carcinoma. Antioxidants (Basel). 2026. https:\/\/doi.org\/10.3390\/antiox15060722.","journal-title":"Antioxidants (Basel)"},{"key":"3399_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.103007","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zhou CT, Ren XY, et al. Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2023.103007.","journal-title":"Redox Biol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03399-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:38Z","timestamp":1792096898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03399-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":161,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3399"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03399-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"268"}}